Liang Shuo-Wen, Wang Ning-Chi, Wang Yung-Chih
Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
Infect Drug Resist. 2025 Aug 18;18:4157-4164. doi: 10.2147/IDR.S544358. eCollection 2025.
Paraspinal steroid injections, while widely employed for the treatment of back pain, carry risks of serious complications including infection. We describe a 54-year-old immunocompetent woman who developed a disseminated methicillin-resistant (MRSA) infection following a lumbar paraspinal steroid injection for back pain. She presented with fever, dyspnea, and acute low back pain, progressing to hypoxic respiratory failure requiring intubation. Diagnostic workup revealed MRSA bacteremia complicated by a lumbar spinal epidural abscess, bilateral psoas and quadratus lumborum pyomyositis, inferior vena cava (IVC) septic thrombophlebitis, pulmonary septic emboli, and meningoencephalitis. The patient received intravenous vancomycin and anticoagulation therapy with apixaban. Clinical improvement was observed with resolution of bacteremia and complete radiological resolution of the IVC thrombus after completing an 8-week treatment course. This case underscores the devastating potential of MRSA to transform a localized infection into widespread metastatic disease, driven by its potent virulence factors. It points out the importance of early recognition of systemic complications, including vascular thrombosis and central nervous system involvement, following paraspinal interventions. Moreover, it demonstrates the need for prompt imaging, timely administration of targeted antibiotics, and multidisciplinary management. Given the increasing use of corticosteroid injections and rising concerns about antibiotic-resistant pathogens, this case serves as a reminder of potential iatrogenic complications and the critical importance of infection control and vigilant monitoring. Clinicians should maintain a high index of suspicion for deep-seated infections in patients presenting with systemic symptoms after steroid injection, even in the absence of overt immunosuppression.
椎旁类固醇注射虽然广泛用于治疗背痛,但存在包括感染在内的严重并发症风险。我们描述了一名54岁免疫功能正常的女性,她在接受腰椎椎旁类固醇注射治疗背痛后发生了播散性耐甲氧西林金黄色葡萄球菌(MRSA)感染。她出现发热、呼吸困难和急性下背痛,进展为需要插管的低氧性呼吸衰竭。诊断检查发现MRSA菌血症并发腰椎硬膜外脓肿、双侧腰大肌和腰方肌脓性肌炎、下腔静脉(IVC)感染性血栓性静脉炎、肺感染性栓子和脑膜脑炎。患者接受了静脉注射万古霉素和阿哌沙班抗凝治疗。在完成8周的治疗疗程后,观察到临床改善,菌血症消退,IVC血栓在影像学上完全消失。该病例强调了MRSA凭借其强大的毒力因子将局部感染转变为广泛转移性疾病的巨大潜在危害。它指出了在椎旁干预后早期识别包括血管血栓形成和中枢神经系统受累在内的全身并发症的重要性。此外,它表明需要及时进行影像学检查、及时给予针对性抗生素以及多学科管理。鉴于皮质类固醇注射的使用增加以及对抗生素耐药病原体的担忧加剧,该病例提醒人们注意潜在的医源性并发症以及感染控制和密切监测的至关重要性。对于类固醇注射后出现全身症状的患者,即使没有明显免疫抑制,临床医生也应高度怀疑深部感染。